San Francisco, CA · Founded 2024 · Privately Held (backing)
Operator of biopharmaceutical development services intended for translational research and global licensing purposes. Expedition Therapeutics is based in San Francisco, CA and was founded in 2024. It was valued at $1 billion at its Series B in Aug 2026, the last priced event on record. It has raised $165 million across 1 recorded round; the latest was an $115 million Series B in Aug 2026.
PMV mark · valuation
$1.0B
Oct 2026
Priced at
its Series B
Aug 2026
Total raised
$165.0M
Last round
Series B
Aug 2026
No prints on record
No secondary trades in Expedition Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Expedition Therapeutics with a free account
·The post-money valuation on its round
·The complete investor list: 14 names
·Watch Expedition Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Expedition Therapeutics stock.
